The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
GLP-1 medications, while effective for weight loss, can have various side effects. Understanding these potential impacts is crucial for informed decision-making and patient care. These medications affect different parts of the body, leading to diverse reactions based on individual physiology.
ShantaQuilette Carter-Williams shares her experience with GLP-1 medication after a health ultimatum. Discover how it transformed her life, health habits, and perspective on self-care.
New research reveals that medications like Ozempic are associated with considerable decreases in household food expenditures, both in grocery stores and restaurants. The study highlights how the adoption of GLP-1 drugs impacts daily food purchasing in real-world scenarios, showing a notable shift in consumer behavior.
ShantaQuilette Carter-Williams shares her experience with GLP-1 medications after facing serious health issues. Her story highlights the transformative impact on her health, lifestyle, and relationships.
In response to the increasing demand for GLP-1 weight-management solutions and the risks associated with unregulated online sales, FastMed has launched a program providing a secure and compliant channel for individuals seeking weight management assistance. The platform emphasizes the importance of medical supervision when using prescription weight-loss medications.
WeightWatchers is undergoing a brand refresh to better integrate GLP-1 medications into its offerings. This shift comes after the company's bankruptcy filing, which cited the rapidly evolving weight management landscape. The rebrand includes new programs and features designed to support members using these medications.
The GLP-1 agonist market is undergoing significant expansion, fundamentally changing how Type 2 Diabetes and obesity are addressed globally. This drug class, initially for glycemic control, has become a key therapeutic option for weight management and cardiovascular risk reduction. The rising popularity of these drugs has sparked a pharmaceutical boom, with focus shifting to advanced agonists offering even greater metabolic advantages.
The increasing use of GLP-1 drugs is reshaping the food and beverage industry. Circana's research highlights how retailers and manufacturers can adapt to meet the evolving needs of health-conscious consumers.
With the introduction of new weight-loss and diabetes drugs like Ozempic in India, endocrinologists are emphasizing the need for cautious and medically supervised use. Concerns arise particularly for individuals with a 'thin-fat' phenotype, who may experience adverse effects.
